Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Claude Fromentin is active.

Publication


Featured researches published by Claude Fromentin.


Bioorganic & Medicinal Chemistry Letters | 1999

Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens.

Alexis Denis; Constantin Agouridas; Jean-Michel Auger; Yannick Benedetti; Alain Bonnefoy; Francois Bretin; Jean-Francois Chantot; Arlette Dussarat; Claude Fromentin; Solange Gouin d'Ambrieres; Sylvette Lachaud; Patrick Laurin; Odile Le Martret; Véronique Loyau; Nicole Tessot; Jean-Marie Pejac; Sébastien Perron

In the search for new ketolides with improved activities against erythromycin-resistant S. pneumoniae and H. influenzae we synthesized a new 11,12 carbamate ketolide substituted by an imidazo-pyridyl side chain: HMR 3647. This compound demonstrated a potent activity against erythromycin susceptible and resistant pathogens, including penicillin G/erythromycin A-resistant S. pneumoniae and H. influenzae. In vivo, HMR 3647 displayed good pharmacokinetic parameters (Cmax = 2.9 microg/ml, bioavailability=49%, AUC0.8 = 17.2 microg.h/l, t1/2=1h) and was shown to have a high therapeutic efficacy in mice infected by various respiratory pathogens, including multi-resistant S. pneumoniae and Gram negative bacteria such as H. influenzae. HMR 3647 appears to be a very promising agent for the treatment of respiratory infections and is currently in clinical trials.


Bioorganic & Medicinal Chemistry Letters | 2000

β-Keto-ester chemistry and ketolides. synthesis and antibacterial activity of 2-halogeno, 2-methyl and 2,3 enol-ether ketolides

Alexis Denis; Francois Bretin; Claude Fromentin; A Bonnet; Alain Bonnefoy; Constantin Agouridas; G Piltan

The effect of 2,3 modifications on the antibacterial activity of ketolides was evaluated by introducing substituents in position 2 and converting the C-1, C-2, C-3 beta-keto-ester into stable 2,3 enol-ether or 2,3 anhydro derivatives. Introduction of a fluorine in C-2 is beneficial with regard to the overall antibacterial spectrum whereas the enol-ether and 2,3 unsaturated compounds, as well as the bulky gem dimethyl or 2-chloro derivatives, are less active particularly against erythromycin resistant strains. A 2-fluoro ketolide derivative demonstrates good antibacterial activity and in vivo efficacy against multi-resistant Streptococcus pneumoniae. Compared to azithromycin against Haemophilus influenzae, this compound is equivalent in vitro and slightly more active in vivo. These results demonstrate that within the ketolide class, to retain good antibacterial activity, position 2 needs to remain tetrahedral and tolerates only very small substituents such as fluorine.


Journal of Medicinal Chemistry | 1998

Synthesis and Antibacterial Activity of Ketolides (6-O-Methyl-3-oxoerythromycin Derivatives): A New Class of Antibacterials Highly Potent Against Macrolide-Resistant and -Susceptible Respiratory Pathogens†

Constantin Agouridas; Alexis Denis; Jean-Michel Auger; Yannick Benedetti; Alain Bonnefoy; Francois Bretin; Jean-Francois Chantot; Arlette Dussarat; Claude Fromentin; Solange Gouin d'Ambrieres; Sylvette Lachaud; Patrick Laurin; Odile Le Martret; and Véronique Loyau; Nicole Tessot


Archive | 2001

Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents

Maxime Lampilas; Jozsef Aszodi; David Alan Rowlands; Claude Fromentin


Archive | 2004

Heterocyclic compounds as inhibitors of beta-lactamases

Jozsef Aszodi; Claude Fromentin; Maxime Lampilas; David Alan Rowlands


Archive | 2003

Heterocyclic compounds which are active as inhibitors of beta lactamases

Jozsef Aszodi; Claude Fromentin; Maxime Lampilas; David Alan Rowlands


Archive | 2006

Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents

Maxime Lampilas; Jozsef Aszodi; David Alan Rowlands; Claude Fromentin


Archive | 2000

Derivatives of erythromycin, their preparation process and their use as medicaments

Constantin Agouridas; Alexis Denis; Claude Fromentin


Archive | 1999

DERIVATIVES ...USE AS MEDICAMENTS

Constantin Agouridas; Alexis Denis; Claude Fromentin


Archive | 2002

Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases

Jozsef Aszodi; Maxime Lampilas; Claude Fromentin; David Alan Rowlands

Collaboration


Dive into the Claude Fromentin's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge